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Background: The Nef protein of HIV facilitates virus replication and disease progression in infected patients. This
role as pathogenesis factor depends on several genetically separable Nef functions that are mediated by
interactions of highly conserved protein-protein interaction motifs with different host cell proteins. By studying the
functionality of a series of nef alleles from clinical isolates, we identified a dysfunctional HIV group O Nef in which a
highly conserved valine-glycine-phenylalanine (VGF) region, which links a preceding acidic cluster with the
following proline-rich motif into an amphipathic surface was deleted. In this study, we aimed to study the
functional importance of this VGF region.
Results: The dysfunctional HIV group O8 nef allele was restored to the consensus sequence, and mutants of
canonical (NL4.3, NA-7, SF2) and non-canonical (B2 and C1422) HIV-1 group M nef alleles were generated in which
the amino acids of the VGF region were changed into alanines (VGF!AAA) and tested for their capacity to
interfere with surface receptor trafficking, signal transduction and enhancement of viral replication and infectivity.
We found the VGF motif, and each individual amino acid of this motif, to be critical for downregulation of MHC-I
and CXCR4. Moreover, Nef’s association with the cellular p21-activated kinase 2 (PAK2), the resulting deregulation of
cofilin and inhibition of host cell actin remodeling, and targeting of Lck kinase to the trans-golgi-network (TGN)
were affected as well. Of particular interest, VGF integrity was essential for Nef-mediated enhancement of HIV virion
infectivity and HIV replication in peripheral blood lymphocytes. For targeting of Lck kinase to the TGN and viral
infectivity, especially the phenylalanine of the triplet was essential. At the molecular level, the VGF motif was
required for the physical interaction of the adjacent proline-rich motif with Hck.
Conclusion: Based on these findings, we propose that this highly conserved three amino acid VGF motif together
with the acidic cluster and the proline-rich motif form a previously unrecognized amphipathic surface on Nef. This
surface appears to be essential for the majority of Nef functions and thus represents a prime target for the
pharmacological inhibition of Nef.
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Primate immunodeficiency virus Nef is a 25–35 kDa pro-
tein expressed by a conserved open reading frame, which
partially overlaps with the 3 long terminal repeat (LTR) in
the genome of HIV-1, HIV-2 or simian immunodeficiency
virus (SIV). Nef is expressed early in the viral life cycle
and is required for efficient viral replication and disease
progression in the infected host. Therefore, the absence of
Nef slows down or completely abolishes the progression
towards acquired immunodeficiency syndrome (AIDS)
[1,2]. Interestingly, a strong selective pressure has been
demonstrated for a functional nef gene, since macaques
infected with non-pathogenic, SIV nef-mutant show
in vivo repair of the reading frame and subsequent pro-
gression to AIDS-like disease [3]. Moreover, isolated ex-
pression of Nef in transgenic mice induces a strong
depletion of CD4+ cells, resembling an AIDS-like pheno-
type [4,5]. Additionally, cohorts of patients infected with
HIV variants harboring Nef mutations and/or deletions in
nef show a delayed onset of AIDS. While these studies
clearly established Nef as a critical factor for AIDS patho-
genesis, the underlying molecular mechanism remains to
be fully elucidated.
Nef associates with host cell membranes through the
N-terminal myristoyl group and functions as an adaptor
protein, promoting viral pathogenicity probably by inter-
acting with several classes of host cell proteins, mainly
protein kinases and components of the endocytic traf-
ficking machinery. For instance, Nef reduces surface ex-
pression of the HIV entry receptor CD4 and co-
receptors CCR5 and CXCR4 to prevent superinfection
of already productively infected cells and possibly aiding
virion release from these cells [5-9]. Nef also leads to
reduced cell surface expression of MHC class I and
MHC class II molecules to facilitate immune evasion of
infected cells [6-8]. Finally, Nef interferes with the T cell
receptor signal transduction machinery and enhances
virion infectivity and viral replication [9,10].
Mutational analysis revealed that individual actions of
Nef have distinct structural correlates. The protein has a
flexible, myristoylated N-terminal anchor domain of vari-
able length followed by a loop section containing a pro-
line-rich type II helix, a core domain and a C-terminal
flexible loop containing an endocytic di-leucine based
sorting motif that is required for most trafficking func-
tions of Nef [11]. Specifically, downregulation of CD4
requires conserved amino acid residues located at the N-
terminal arm and the disordered C-terminal loop of Nef,
whereas downregulation of MHC-I and CXCR4 depend
on a cluster of acidic amino acid residues (EEEE, stretch
of glutamic or aspartic acids) as well as the neighboring
proline-rich motif that is part of a Src homology domain 3
(SH3) binding surface of Nef (PxxPxVPxRP, first four
amino acids represented by PxxP, x is an unspecifiedamino acid). A large number of cellular partners have
been identified and for some of them the binding sites on
Nef have been mapped [11,12].
In this study, we analyzed a panel of HIV-1 and HIV-2
nef alleles derived from clinical HIV isolates and identi-
fied a nef allele that was naturally mutated in an amphi-
pathic stretch of amino acids in the PxxP loop region,
compromising both the acidic cluster and the proline-
rich motif. Analysis of this and other Nef mutants
revealed a crucial role of the three amino acid valine-gly-
cine-phenylalanine (VGF) motif which links the acidic
cluster to the proline-rich motif. Without affecting the
stability of the protein, specific mutations of the VGF
motif interfered with a wide variety of Nef functions
which are known to depend on the integrity of the pro-
line-rich motif, including MHC-I and CXCR4 downre-
gulation, association of PAK2 and Hck kinases and
interference with T cell receptor signaling as well as en-
hancement of viral infectivity and replication. For sur-
face receptor trafficking and cytoskeletal functions each
individual amino acid of the triplet is important; while
for targeting of Lck kinase to the trans-golgi-network
and viral infectivity, especially the phenylalanine of the
triplet was essential. We propose that the highly con-
served three amino acid VGF motif together with the
adjacent acidic cluster and proline-rich motif form a
previously unrecognized amphipathic surface on Nef
that is essential for the majority of Nef functions.
Results
Nef alleles from different clades of HIV isolates modulate
surface expression levels of human receptors
Nef downregulates the expression of cell surface mar-
kers, such as CD4, MHC-I and CXCR4. We initially set
out to extend available data on the conservation of these
functions [13-15] in a series of clinical HIV-1 (NIH AIDS
Reference and Reagent Program) and HIV-2 isolates (In-
stitute for Tropical Medicine, Antwerp, Belgium) that we
used before to assess viral fitness hierarchy [16]. Nef
alleles were sequenced (Additional file 1: Figure S1) and
amplified from infected PBMCs and expressed by retro-
viral transduction in Jurkat CD4-CCR5 cells. Transduced
cells were subsequently analysed by flow cytometry for
surface receptor levels. Transduced cells express both
Nef and an eGFP marker protein at correlating levels
[17]. As a control, we included a virus encoding for
eGFP only. In order to quantify the extent of receptor
downregulation, the ratio between the mean fluorescence
intensity (MFI) of transduced cells (eGFP+) was divided by
the MFI of untransduced cells in the same culture. Ex-
pression of all nef alleles resulted in at least 5-fold de-
crease of CD4 surface expression, confirming the
functionality of these Nef proteins. However, the effect of
the isolated nef alleles on MHC-I and CXCR4 surface
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the isolated HIV-1 group M, HIV-1 group O and HIV-2
Nef proteins downmodulated the expression of MHC-I
and CXCR4 resulting in a 2- to 3-fold reduction in surface
expression. Interestingly, two HIV-1 subtype C alleles
(VI1044 and VI794; Figure 1 and 1B) and one HIV-1
group O allele (O8) did not show any effect on MHC-I
downregulation (Figure 1C and 1D). All Nef proteins, ex-
cept Nef O8 and HIV-2 VI171, downregulated the surface
expression of CXCR4 (Figure 1C and 1D). In line with
previous reports [15], nef alleles isolated from HIV-2
strains were much more efficient in downregulating
CXCR4 than HIV-1 nef alleles (near 10-fold reduction of
CXCR4 surface expression for HIV-2 compared to 2-3-
fold for HIV-1). Clearly, there was no correlation between
the ability of various Nef proteins to downregulate
CXCR4, MHC-I and CD4, confirming that the mechan-
isms of CD4 and MHC-I downregulations are at least in
part genetically separable [15,18,19] and also suggesting
that downregulation of CXCR4 and MHC-I depend on
the interaction of Nef with distinct cellular ligands and
machineries.
Mutational analysis of the natural Nef mutant HIV-1 O8
In our panel of primary nef alleles, we identified 4 nef
alleles that were deficient for MHC-I and/or CXCR4
downregulation. A subtype C nef allele (VI1044) con-
tained an insertion of a few amino-acids, which inter-
rupted the structure of the N-proximal α-helical
region, explaining the lack of MHC-I downregulation
capacity of this allele (Additional file 1: Figure S1C)
[20]. Nef alleles VI794 (subtype C) and VI171 (HIV-2)
did not show any mutations in regions known to be
important for Nef functions (Additional file 1: Figure
S1C and Figure S1D). By contrast, Nef O8 showed
mutations in an amphipathic stretch of amino acids in
the Nef core domain encompassing the acidic cluster
and the proline-rich motif (Figure 2A). More specific-
ally, a point mutation changed the first proline of the
polyproline stretch into an alanine. In addition to this
point mutation in the PxxP motif, Nef O8 also showed
a deletion of a three peptidic motif, i.e. valine-glycine-
phenylalanine (VGF), located right in between the
acidic cluster and the polyproline stretch. Based on the
sequences found in the Los Alamos HIV sequence
database consulted in December 2011, the VGF was
highly conserved in HIV-1 and SIVcpz (V: 99.20 %; G:
98.85 %; F: 99.52 %). [21,22]. HIV-2 nef alleles instead
contain a highly conserved VGV motif (V: 93.06 %; G:
97.22 %; V: 79.17 %, [22]) indicating that these residues
are important for optimal Nef function. Despite inten-
sive research on the functions of conserved regions in
Nef, the importance of the VGF/V region has not yet
been appreciated or investigated thoroughly.To evaluate the individual contribution of the observed
mutations for the defective phenotype of the O8 nef al-
lele, we generated a panel of mutants in which the differ-
ent mutations were sequentially reverted to their
consensus variant (Figure 2A) and re-evaluated their abil-
ity to downregulate surface molecules. Neither restor-
ation of the AxxP sequence into PxxP (i.e. EDED_PxxP)
nor introduction of the deleted amino acids (i.e.
EDED_VGF_AxxP) restored the capacity to interfere
with MHC-I and CXCR4 surface expression (Figure 2B
and 2C). Only simultaneous restoration of the PxxP and
the VGF motif into the consensus variant (i.e.
EDED_VGF_PxxP or EEEE_VGF_PxxP) rescued CXCR4
and MHC-I downregulation by O8 Nef. Interestingly,
when all three amino acids of the VGF motif in Nef O8
were converted into alanine (i.e. EDED_AAA_PxxP), in
the presence of an intact polyproline stretch, the cap-
acity to affect MHC-I and CXCR4 surface expression
was again lost (Figure 2B and 2C), indicating that spe-
cific amino acids in both motifs are important.
An amphipathic surface in Nef is important for
downregulation of CXCR4 and MHC
Depiction of the VGF motif within the structure of Nef
showed that this motif is located within a loop region of
Nef directly preceding the PxxP motif (Figure 3A). The
motif is at the surface of Nef and highly accessible for
protein-protein interactions [23]. To prove the func-
tional conservation of the VGF motif, we initially evalu-
ated the importance of this domain for MHC-I and
CXCR4 downregulation in nef alleles derived from HIV-
1 group M, two canonical group (M) subtype B strains
(i.e. NL4.3 and NA-7) and two non-canonical isolates:
subtype B (i.e. B2) and subtype C (i.e. VI1422). Muta-
tions were designed to generate triple mutations of VGF
into alanines (VGF!AAA).
To exclude the possibility that the introduced mutation
could affect the stability of the Nef protein, we trans-
duced Jurkat T cells to express wild type (WT) Nef pro-
teins and their mutant counterparts and evaluated their
expression by Western blotting (Figure 3B). Equal
amounts of Nef protein were present in sorted cell
lysates, indicating that the VGF to AAA mutation did
not affect the stability of the protein. Next, we evaluated
the influence of these mutant Nef proteins on surface re-
ceptor expression. Analysis of the surface expression of
CD4, CXCR4 and MHC-I by flow cytometry did not
reveal a deleterious effect of VGF!AAA mutation on
CD4 downregulation of all nef alleles analyzed, indicating
that the expressed Nef mutants retained this function
(Figure 3C), as did O8 Nef. However, these mutants were
completely defective for MHC-I and CXCR4 downregula-
tion (Figure 3D and 3E). This finding indicates that the
VGF motif is not only important for downregulation of
Figure 1 (See legend on next page.)
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Figure 2 Mutational analysis of Nef O8 identifies functional importance of the VGF region which links the acidic cluster and the
proline-rich motif. (A) Alignment of the sequence of Nef O8 relative to a subtype O reference allele (O.BE.87.ANT70) obtained from the Los
Alamos HIV sequence database reveals that the VGF motif is deleted in Nef O8. In addition, the first proline of the PxxP motif changed into
alanine. A panel of mutants was generated in which the different mutations were sequentially reverted to their consensus variant (marked in red)
or to a variant in which VGF was changed into triple alanines (AAA; blue). As reference, boxes below reverted sequences mark the acidic cluster
(Ac) and proline-rich motif (Proline-motif) (B) Jurkat CD4-CCR5 cells were transduced with retroviral vectors expressing either eGFP alone or
together (Nef-IRES-eGFP) with the indicated nef mutant and were analyzed by flow cytometry. Bivariate dot plots show expression of CD4, MHC-I,
CXCR4 as a function of eGFP (Nef) expression. Dot plots shown are representative for results obtained in 3 independent experiments. (C) To
determine relative surface levels, the MFI of transduced cells (eGFP+) was divided by the MFI of untransduced cells (eGFP-) in the same culture.
Data represent the mean relative expression and standard deviations from 3 independent experiments. * over a bar indicates a statistically
significant difference between the experimental construct compared with the eGFP control (P< 0.01).
(See figure on previous page.)
Figure 1 Effect of primary HIV-1 and HIV-2 Nef proteins on surface receptor expression. Jurkat CD4-CCR5 cells were transduced with
retroviral vectors expressing the indicated nef alleles and eGFP (Nef-IRES-eGFP) and were analyzed by flow cytometry. (A and C) Bivariate dot
plots show expression of CD4, MHC-I, CXCR4 as a function of eGFP (Nef) expression. Dot plots shown are representative of results obtained in at
least 3 independent experiments. (B and D) To determine relative CD4, MHC-I and CXCR4 surface levels, the MFI of transduced cells (eGFP+) was
divided by the MFI of untransduced cells (eGFP-) in the same culture. Data represent the mean relative expression and standard deviations from
at least 3 independent experiments. eGFP represents the value for control transduced cells expressing only the marker gene but no Nef. An
asterisk (*) over a bar indicates a statistically significant difference between the experimental construct compared with the eGFP control (P< 0.01).
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Figure 3 The VGF linker region is critical for downregulation of CXCR4 and MHC-I by HIV-1 Nef. To evaluate the functional importance,
VGF!AAA mutants of several Nef proteins were expressed and evaluated for their effect on cell surface receptor expression. (A) Display of the
VGF motif in the structure of NefSF2 (yellow ribbon) bound to an Hck-SH3 domain (blue ribbon). VGF residues, which are deleted in Nef allele O8,
are indicated as space-filling model. Residues of the preceding acidic cluster and the following PxxP motif are shown as stick representation. The
structure is based on PBD accession number 3REA [23]. (B) WT or VGF!AAA Nef-IRES-eGFP transduced Jurkat CD4-CCR5 cells were sorted, lysed
and analyzed for Nef expression. The figure shows a Western blot of whole cell lysates stained with sheep-anti-Nef antiserum. The marker line
indicates position of a 28 kDa standard. Loading control staining (actin) was similar over all samples (not shown). (C-E) Relative CD4, MHC-I,
CXCR4 surface levels measured by flow cytometry on Jurkat CD4-CCR5 cells transduced with retroviral vectors expressing either eGFP alone or
together with the indicated nef alleles and mutants. To determine relative surface levels, the MFI of transduced cells (eGFP+) was divided by the
MFI of untransduced cells (eGFP-) in the same culture. Data represent the mean relative expression and standard deviations obtained from 3
independent experiments, wild-type allele (open columns) next to the corresponding VGF!AAA mutants (grey shaded columns). *** over a bar
indicates a statistically significant difference between the VGF!AAA mutant compared to the wild-type allele (P< 0.001).
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group M Nef proteins.
Each amino acid residue of the VGF motif is highly
conserved, suggesting a sequence specific requirement.
However, the triple mutation of the VGF stretch might
be structurally drastic and alter the functionality of adja-
cent motifs. To exclude this and to confirm the se-
quence specific requirement of the VGF motif, a panel
of single mutants of the VGF motif, in which the differ-
ent amino acids are changed into alanine (AGF, VAF and
VGA), was generated and evaluated for their effect on
Nef function. Similarly to the VGF!AAA mutant, single
mutants failed to down regulate MHC-I and CXCR4,while maintaining the capacity to downregulate CD4
(Figure 4). These results indicate that the VGF stretch as
such is required for downregulation of MHC-I and CXCR4.
Integrity of the VGF motif is essential for effects of Nef on
actin dynamics and Lck localization
Due to the spatial proximity of the VGF motif to the
polyproline stretch containing the PxxP-motif, we won-
dered whether both motifs support distinct functions of
Nef or are integrated into one larger protein binding sur-
face. To address this point we analyzed Nef functions in
addition to MHC-I and CXCR4 downregulation known
to depend on the PxxP motif and focused first on the
Figure 4 (See legend on next page.)
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Figure 4 Sequence specific requirement of V-G-F for Nef function. Panels A to C show relative surface levels of CD4, MHC-I, CXCR4
respectively, measured by flow cytometry on Jurkat CD4-CCR5 cells transduced with retroviral vectors expressing either eGFP alone or together
with the indicated nef alleles and mutants. To determine relative surface levels, the MFI of transduced cells (eGFP+) was divided by the MFI of
untransduced cells (eGFP-) in the same culture. Data represent the mean relative expression and standard deviations obtained from 3
independent experiments,** over a bar indicates P< 0.01 and *** indicates P< 0.001.
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2 (PAK2) [24]. Nef-PAK2 association occurs in a highly
labile multiprotein complex of about 1 MDa and causes
the phosphorylation and thereby inactivation of the actin
severing factor cofilin [25,26]. While the instability of the
Nef-PAK2 complex limits the reliability of biochemical
quantification of this association between different nef
alleles [24,26,27], the functional consequences including
PAK2-dependent deregulation of cofilin and inhibition of
actin dynamics can readily be quantified and are con-
served among most Nef isolates [26,28]. We therefore
analyzed the ability of Nef VGF!AAA mutants from SF2
and NA7 Nef to induce hyper-phosphorylation of cofilin
downstream of PAK2, using a previously established sin-
gle cell-based immunofluorescence quantification assay
[20,21]. As expected, cofilin was hyper-phosphorylated in
Jurkat T cells expressing WT SF2 and NA-7 Nef, but not
in the presence of their AxxA mutants. Similarly,
VGF!AAA mutated Nef failed to induce cofilin phos-
phorylation (Figure 5A and 5B), suggesting that the VGF
motif is essential for Nef-PAK2 association. To address
this point directly, we performed an in vitro kinase assay
to analyze the association of Nef with PAK2 activity.
GFP-tagged SF2 Nef was used for this analysis due to
more robust kinase signal detected with this Nef allele.
Nef.GFP was immunoprecipitated from transiently trans-
fected Jurkat T cells and subsequently subjected to an
in vitro kinase assay, in which Nef-PAK2 association is
detected by the presence of autophosphorylated PAK2
(62 kDa; p-PAK2) as well as of a yet unindentified 72 kDa
substrate (p72). Expectedly [26,29], WT SF2 Nef but not
its AxxA mutant efficiently associated with autopho-
sphorylating PAK2; however, SF2 AxxA Nef was also
expressed to lower levels than the WT in the experiment
shown. In line with the results obtained from the cofilin-
phosphorylation analyses, the VGF Nef mutant failed to
associate with PAK2 activity despite robust expression
and efficient immune isolation (Figure 5C). Since the de-
regulation of cofilin by Nef results in impaired host cell
actin remodeling following external stimulation, we next
analyzed the role of the VGF motif for the Nef-dependent
inhibition of actin remodeling following TCR-signaling
[28,30,31]. T cells transiently expressing GFP-tagged ver-
sions of WT, AxxA or VGF!AAA mutants from SF2 or
NA7 Nef were plated onto anti-CD3 coated cover glasses
and analyzed for the formation of circumferential F-actin
rich rings by immuno fluorescence analysis. Expectedly,WT Nef expressing cells interfered with actin remodeling
and prevented the formation of F-actin rich circumferen-
tial rings: as shown in Figure 4D, no actin ring is visible
around green cells expressing WT Nef. In contrast, AxxA
and VGF!AAA Nef variants were not able to interfere
with actin polymerization (Figure 5D and 5E), so a clear
circumferential staining is visible, despite Nef mutant pro-
tein expression.
Similar to the VGF!AAA mutants, single mutants of
the VGF motif (AGF, VAF and VGA) were significantly
reduced in their effect on cofilin phosphorylation (Fig-
ure 5A and 5B) and actin polymerization (Figure 5D and
5E). It should, however, be noted that these single
mutants had a slight but significant residual effect as
compared to the triple mutant, indicating that some re-
sidual activity remains for the alleles, especially for the
VGF!AGF and VGF!VAF mutants. Nevertheless,
these results demonstrate that the VGF motif in different
nef alleles is critical for Nef-PAK2 association and thus
consequential for Nef-mediated cofilin deregulation and
disruption of host cell actin remodelling.
The above results demonstrated for different nef alleles
a requirement for both the PxxP and the VGF motif in
Nef-PAK2 association and cell surface receptor down
modulation. All of these activities, however, also depend
on additional protein interaction motifs in Nef such as
an intact protein interaction surface around aa191/195
or the acidic cluster [32] and thus did not allow us to
conclude unambiguously whether the VGF and PxxP
motifs exert independent functions or synergize in a
common molecular interaction. We, therefore, assessed
next the role of the VGF motif in Nef-mediated targeting
of the TCR proximal kinase Lck to the trans-golgi
network (TGN), a function of Nef for which so far
no protein interaction surface in Nef other than the
the PxxP motif has been implicated [30,33,34]. Jurkat
T cells transiently expressing GFP-tagged Nef proteins
were analyzed for TGN accumulation of Lck by im-
munofluorescence analysis. While Lck appeared
mostly at the plasma membrane with a minor intra-
cellular fraction in GFP- and Nef AxxA-expressing
cells, WT Nef expression resulted in a pronounced
intracellular accumulation indicative of TGN targeting
of the kinase (Figure 6A) as described previously [33].
VGF!AAA Nef mutants displayed intermediate activ-
ity in this assay and failed to affect the subcellular
localization of Lck in most cells; however, some cells
Figure 5 The VGF region is important for Nef-PAK2 association, cofilin hyper- phopsorylation and inhibition of F-actin rich
circumferential ring formation by Nef. (A) Jurkat TAg cells were transfected arrows with WT, AxxA, VGF!AAA, VGF!AGF, VGF!VAF or
VGF!VGA mutant Nef.GFP fusion proteins, plated onto poly-L-lysine (PLL)–coated cover glasses, fixed and stained for phospho-cofilin (p-cofilin).
Images show intense staining for p-cofilin (red-orange) only in cells expressing Nef (green) of wild-type, but not of mutated sequence. Scale
bar = 10 μm (B) Frequency of the cells from cultures as shown in panel A that were scored high in p-cofilin. Values are the means of 3
independent experiments, and error bars represent SD from the mean; ≥ 100 cells were analyzed per transfection; * indicates P< 0.01, **
indicates P<0.001 and *** indicates P< 0.0001. (C) Lysates of Jurkat TAg cells expressing eGFP or WT, VGF!AAA or AxxA SF2 Nef.GFP fusion
proteins. Lower panels (input) show Western blot for Nef and loading control (transferrin receptor). These lysates were immunoprecipitated for
Nef.GFP (rαGFP-IP), and subsequently used for in vitro kinase assay (IVKA). Nef-PAK2 association is detected in the IVKA only with WT Nef, by the
presence of autophosphorylated PAK2 (62 kDa; p-PAK2) as well as of a yet unindentified 72 kDa substrate (p72). (D) Jurkat TAg cells were
transfected with WT, AxxA, VGF!AAA, VGF!AGF, VGF!VAF or VGF!VGA mutant Nef.GFP fusion proteins, plated onto anti-CD3–coated cover
glasses, fixed and stained with phalloidin to reveal F-actin (red). Scale bar = 10 μm (E) Frequency of the cells from cultures as shown in panel A
that to form F-actin–rich circumferential rings. Values are the means of 3 independent experiments, and error bars represent SD from the mean;
≥ 100 cells were analyzed per transfection, * indicate P< 0.01, ** indicates P<0.001 and *** indicates P< 0.0001.
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ures 6A and 6B). In contrast, single substitutions of
the valine (VGF!AGF) and the glycine (VGF!VAF)
respectively did not or did marginally affect Lck accu-
mulation. However, mutation of the phenylalanine,(VGF!VGA) was sufficient to abrogate this Nef func-
tion similar to the VGF!AAA mutant, indicating that
Lck accumulation by Nef depends at least in part on
the VGF motif and that the phenylalanine which dir-
ectly precedes the proline-rich stretch is crucial for this.
Figure 6 The VGF region is important for the interaction of Nef with Lck and Hck. (A) Jurkat TAg cells were transfected arrows with WT,
AxxA, VGF!AAA, VGF!AGF, VGF!VAF or VGF!VGA mutant Nef.GFP fusion proteins, plated onto poly-L-lysine (PLL)–coated cover glasses, fixed
and stained for Lck (red): wild-type but not AxxA Nef induces Lck accumulation (arrow heads), Images shown are representative for all cells
analyzed. Scale bar = 10 μm (B) Frequency of the cells from cultures as shown in panel A that show Lck accumulation. Values are the means of 3
independent experiments, and error bars represent SD from the mean; ≥ 100 cells were analyzed per transfection, ** indicates P< 0.001 and
*** indicates P< 0.0001. (C) Western blot of lysates of 293 T cells co-expressing WT, VGF!AAA, VGF!AGF, VGF!VAF, VGF!VGA or AxxA SF2 or
NA-7 Nef.GFP fusion proteins (all similar fraction of cells positive for GFP) or GFP only together with Hck. Lower panels (input) show staining for
Nef (arrow) and Hck; upper panel shows anti-GFP immunoprecipitation (IP) stained for Hck. Interaction of Nef with Hck was detected as the
presence of Hck isoforms in the immunoprecipitate.
Meuwissen et al. Retrovirology 2012, 9:34 Page 11 of 19
http://www.retrovirology.com/content/9/1/34To address whether the VGF motif is directly involved
in protein interactions of the adjacent PxxP motif, we
probed its impact on the direct interaction of Nef with its
best characterized and highest affinity PxxP ligand, the
Src-family kinase Hck [35]. Nef and Hck were co-
expressed in 293 T cells and Nef.GFP was immunoprecipi-
tated. Subsequently, Co-precipitating Hck was detected by
Western Blot. While different isoforms of Hck co-precipi-
tated efficiently with WT (NA-7 or SF2) Nef, the AxxA
and VGF!AAA Nef mutants were completely defective
in Hck binding. Single amino acid substitution mutants
did not bind the low molecular weight isoform as WT
preferentially did, although some residual binding was
sometimes observed with the high molecular weightisoform (Figure 6C). Together, we concluded that the in-
tegrity of the VGF motif is essential for most, if not all,
functions attributed to the PxxP motif and that both
motifs may be part of a common interaction surface.
The VGF motif is essential for the effect of Nef on viral
infectivity and replication
Nef has been shown to positively affect the replication of
HIV in vivo [2] as well as in cultures of primary cells
[36-38] and ex vivo human lymphoid tissue [39]. Multiple
studies have shown that Nef positively affects viral replica-
tion by enhancing viral release and infectivity [10]. Since
these functions critically rely on the PxxP motif, we
addressed the replication and infectivity of VGF!AAA
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petent HIVNL4.3-based reporter viruses expressing NL4.3
WT, AxxA and VGF!AAA Nef. These viruses express
Nef together with mouse-derived heat stable antigen
(HSA) from a single bicistronic mRNA (HSA-IRES-Nef)
[40]. It was shown before that key activities of Nef such as
enhancement of virion infectivity and increase of viral rep-
lication remain conserved in such chimeric viruses and
that marker gene expression correlates with Nef expres-
sion in productively infected cells [41,42]. As control, weFigure 7 Integrity of the VGF region is required for enhancement of virus
required for enhancement of virus infectivity and replication by Nef.
(either Nef WT, AxxA, VGF!AAA, VGF!AGF, VGF!VAF, VGF!VGA, or Stop
(A) Enhancement of virion infectivity by different Nef mutants in HeLa P4R5
calculated relative to wild-type HIV-1 NL4-3 HSA-IRES Nef. Values are the m
the mean; * indicates P< 0.05, ** indicates P< 0.01 and *** indicates P< 0
isolated peripheral blood CD4+ T cells were stimulated for 48 h with IL-2/P
replication was monitored by determining the amount of p24 antigen in th
virus in CD4+ T cells derived from 3 different donors.also constructed a Nefstop HIV reporter virus, which does
not express Nef due to the insertion of multiple premature
stop codons [43].
We evaluated whether the VGF!AAA mutation
affected the infectivity of HIV particles in HeLa P4R5 β-
galactosidase indicator cells. Cells were infected with
virus preparations corresponding to equal amounts of
p24 and HIV-infection was quantified on the basis of β-
galactosidase activity, 48 h post infection (Figure 7A). As
expected, the Nefstop HIV, deficient in Nef expressioninfectivity and replication by NefIntegrity of the VGF region is
Replication competent HIV-1 NL4.3 HSA-IRES-Nef reporter viruses
) were produced in 293 T cells and quantified by p24 measurement
LTR-β-galactosidase indicator cells. Percentage β-gal levels were
eans of 3 independent experiments, and error bars represent SD from
.001. (B) Replication kinetics in human primary CD4+ T cells. Freshly
HA before infection. After 1, 3, 5, 7, 9 and 11 days of culture, HIV
e supernatants. Plots show the replication kinetics of the HIV reporter
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Both the VGF!AAA and AxxA Nef mutated HIV were
severely less infective. Results shown were obtained with
the NL4-3 nef allele and similar reduction in infectivity
was seen using SF2 and NA-7 nef alleles (data not
shown). Similary to the VGF!AAA mutant of NL4.3
Nef, single mutants were significantly less infective rela-
tive to the wt virus. Of note, single substitution mutants
of the valine (VGF!AGF) and the glycine (VGF!VAF),
but not of the phenylalanine (VGF!VGA), were slightly
more infective than the triple mutation, resulting in an
intermediate phenotype.
As a final functional correlate, we evaluated if the in-
tegrity of the VGF motif is essential for Nef enhanced
HIV replication in peripheral blood lymphocytes (PBL).
CD4+ T cells were isolated and stimulated with IL-2/
PHA, prior to infection with isogenic viruses. Cells were
infected with 293 T-derived viral supernatants corre-
sponding to the same amount of p24. After 1, 3, 5, 7, 9
and 11 days of culture, HIV replication was monitored
by determining the amount of p24 antigen in the super-
natants (Figure 7B). WT NL4.3 HIV-1 replicated much
more efficiently in IL-2 stimulated PBL’s relative to the
nef stop variant. As expected the mutants of the PxxP
motif were less efficient in enhancing viral replication
[44,45]. Similarly, the VGF mutated Nef HIV replicated
less efficiently compared to WT HIV, although the effect
was attenuated in some donors when compared to the
PxxP Nef mutated HIV. All donors tested showed a sig-
nificantly reduced replication rate of HIV VGF!AAA
Nef mutated virus compared to WT Nef HIV. After day
9 of culture, viability in infected cultures decreased sig-
nificantly, explaining the general drop in p24 levels at
day 11. As a control, we also evaluated the amount of
HSA expressing cells at several time points by flow cyto-
metry as an alternative measure for HIV expression,
with similar results (data not shown).
Discussion
Although not essential for viral replication, HIV-1 Nef is
important for disease progression and, therefore, is con-
sidered a pathogenic factor in primate lentiviridae [10].
For its function, Nef depends on specific surfaces to
interact with host cell proteins. Therefore, a strong posi-
tive selection pressure exists to keep the property of
these surfaces conserved [46]. It is key to identify con-
served sites in Nef with functional importance in pro-
tein-protein interactions, since they might serve as
potential target sites for pharmacological intervention.
In the present study, we identified, by functional ana-
lysis of a panel of clinical HIV-1 and HIV-2 nef alleles, a
previously unrecognized conserved region. A HIV-1
group O nef allele, was mutated in an amphipathic
stretch of amino acids located in the core domainencompassing the acidic cluster, a VGF region and the
PxxP motif, resulting in the loss of downregulation of
MHC-I and CXCR4, but not of CD4. By selective muta-
tion of this O8 nef allele back to the consensus sequence,
we show that both an intact PxxP motif in conjunction
with an intact VGF region are needed to restore the defect
in receptor trafficking. We could extend this observation
by showing that the VGF region is essential for the associ-
ation of Nef with active PAK2 and consequently hyper-
phosphorylation of cofilin resulting in the inhibition of
actin remodeling following TCR triggering. In addition,
Nef-induced Lck accumulation in the TGN also requires
integrity of the VGF region. The importance of the pro-
line-rich region for this Nef function has been studied ex-
tensively [10,47]. However, despite its high conservation in
HIV-1 and SIVcpz nef alleles, the function of the VGF re-
gion remained poorly investigated.
Modulation of cell surface molecules such as MHC-I
and chemokine receptors or the TNF receptor-associated
factor TRAF2 were shown to depend on the conserva-
tion of the PxxP motif as well as the acidic cluster
(EEEE) [19,48,49]. How the acidic cluster contributes to
downregulation of MHC-I is controversial. Several stud-
ies have observed that the four contiguous glutamate
residues interact with PACS-1 and PACS-2 to initiate as-
sembly of a multiprotein complex which targets MHC-I
to the trans-Golgi network for subsequent degradation
[50,51]. However, in an alternative model for MHC-I
downregulation, in which Nef interacts with both MHC-
I and the μ subunit of the AP-1 endosomal coat com-
plex, the EEEE motif plays only a stabilizing role [52,53].
The PxxP motif on the other hand is essential for the
interaction of Nef with Src kinases (like Hck); misrout-
ing of Lck as well as association of Nef with the cellular
kinase PAK2, results in elevated cellular levels of inacti-
vated phosphorylated cofilin, a deregulation that is in-
strumental for the inhibition of TCR- or chemokine-
induced F-actin remodeling [26,28-31,34].
Triple mutants of the VGF motif (VGF!AAA) lost both
‘trafficking’ (MHC-I, CXCR4) as well as ‘signaling' (PAK2
association, cofilin hyper-phosphorylation and inhibition
of actin ring formation) functions, suggesting that the
VGF region is functionally linked with the PxxP motif.
Moreover, Baugh et al. showed that similar to the PxxP
motif, MHC-I downregulation, interaction with PAK2,
and to a lesser degree enhancement of virion infectivity
are dependent on the acidic cluster [32]. Our observation
that mutation of VGF into triple alanines similarly abro-
gates these multiple effects of Nef is a hint that the acidic
cluster-VGF-PxxP triplet forms a functional unit import-
ant for protein-protein interactions with host cell factors.
In the dysfunctional Nef O8 allele, the VGF motif is in
fact deleted, but not replaced to varying amino acids by
gene tropism. The effect of the deletion mutation could
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cing between the acidic cluster EEEE motif and the PxxP
motif is required for Nef functionality, i.e. the correct
positioning of the EEEE motif and potentially the pre-
ceding CAWL protease recognition motif with respect
to the Nef core domain. Alternatively, the effect of Nef
dysfunction could be direct through binding of these
amino acids to the primary receptors itself or to any
stimulatory co-factor required for receptor downregula-
tion. As mutation of the VGF motif to AAA in O8 Nef
did not restore the Nef trafficking functions, the effect
of mutation is most likely direct. Our finding that indi-
vidual mutation of the three amino acids (AGF, VAF,
VGA) is sufficient to interfere with the effect of Nef on
receptor trafficking and TCR signaling further supports
this hypothesis and shows that the function of V-G-F is
sequence specific. The integrity of the phenylalanine
appears to be specifically essential for functions related to
the proline-rich motif. In contrast to single mutants of the
valine and the glycine (VGF!AGF and VGF!VAF), sin-
gle mutants of this amino-acid (VGF!VGA) did not ac-
cumulate Lck. Of note, several SH3 binding regions of
mammalian proteins contain a N-terminal phenylalanine,
which is required for efficient ligand binding [54]. These
observations suggest that the effect of Nef on TCR
induced actin remodeling and on Lck targeting to the
TGN are mechanistically different, as was shown before
[30].
Shelton et al. showed recently that the VGFPV region,
in their study identified as the secretion modification re-
gion, forms a specific binding surface for mortalin which
subsequently promotes cellular secretion of extracellular
Nef [55]. The phenotypes which we analysed in this
study are all cell intrinsic and are unlikely to be
explained by differences in levels of extracellular Nef.
The results of Shelton et al. and ours together show that
the VGF region is not just a mere spacer between the
acidic cluster and the proline rich region. Instead, it acts
as an interaction surface, which together with its neigh-
boring motifs forms a functional unit.
Replication of HIV-1 in primary T lymphocytes is
tightly coupled to their activation state. While HIV-1
undergoes early replication events in quiescent CD4+ T
cells, subsequent steps in the viral life cycle require T
cell activation. One of the prime roles of Nef in vivo is
to fine tune activation states in infected T cells [56]. Nef
interferes with TCR proximal signaling to prevent T cell
activation and activation–induced cell death upon anti-
genic stimulation [28,30,31,55], while at the same time
enhancing distal TCR signaling effects to promote pro-
viral expression [33,57,58]. Both functions of Nef depend
on the interaction of several specific SH3-domain con-
taining host cell proteins with the conserved PxxP motif.
For example, the PxxP motif interacts with the SH3-domain of Lck, misrouting the TCR proximal kinase Lck
from the plasma membrane to the trans Golgi-network
(TGN), altering TCR proximal signaling events
[28,30,33,59]. In our HIV replication assay, WT HIV
viruses replicated much more efficiently then HIV Nefstop
viruses. The requirement of PxxP residues for efficient
HIV-1 replication in T-cells is controversial [35,39,44,59].
Lundquist and coworkers did not observe significant differ-
ences between the replication-efficiency of WT, AxxA mu-
tant and polyproline deleted viruses [60], while Saksela and
co-workers reported that AxxA mutant replicate as delta-
Nef viruses [35]. In our hands, the replication of the HIV
Nef AxxA viruses was significantly attenuated compared to
WT viruses. The fact that we use a different proviral back-
bone and other culture methods for CD4+ lymphocyte
stimulation may account for the discrepancy between our
results and observations from others. Similar to Nef AxxA
viruses, VGF!AAA mutants replicated much less effi-
ciently than WT HIV viruses. We recently showed that the
accumulation of Lck is required for TGN-associated Ras-
Erk signaling, which in turn was shown to promote IL-2
production and enhance virus spread [33]. As HIV
viruses harboring AxxA or VGF!AAA mutations in
Nef fail to efficiently accumulate Lck [30], this could ex-
plain the altered replication kinetics of these mutants.
Interestingly, our previous observation that the HIV O8
isolate showed reduced fitness compared to other iso-
lates of the same group might be due to the deletion of
the VGF domain [16].
Despite the opposing findings concerning the role of the
PxxP motif for replication of HIV, there is general consen-
sus that this domain is required for Nef to enhance the in-
fectivity of HIV virions [61-63]. The mechanism by which
Nef enhances viral infectivity remains unclear, but is
thought to involve alterations of specific signaling and
trafficking events in the producer cell. [9]. We observed
that, in line with our other results, VGF!AAA mutants
were similarly less infective than wild type viruses.
In our study, we only analyzed the importance of the
VGF motif in Nef for HIV-1 function. Despite VGF con-
servation in HIV-1 and SIVcpz; HIV-2 and SIVsmm instead
harbor VGV. There are no indications that this change
would result in major functional differences, since PxxP
dependent functions such as downregulation of MHC-I,
accumulation of Lck, deregulation of actin remodeling and
association with PAK2 are well conserved between both
HIV-1 Nef and HIV-2 Nef [26,28]. Moreover, both phenyl-
alanine and valine are hydrophobic amino acids, conserv-
ing the lipophilic character of the entire VGF/V region,
and they are not expected to impose a different ultrastruc-
ture that would imply different host protein interactions.
Rather, the strong conservation of VGF/VGV in HIV/SIV
Nef suggests that such a structural motif is required for
function of acidic cluster-VGF/V-PxxP motifs in general.
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Our results extend the previous research performed on
the function of the PxxP motif. Based on our and earlier
observations from other groups, we propose a new model
in which the PxxP motif operates in the context of a larger
amphipathic protein surface, encompassing both the
acidic cluster and the VGF linker region. Moreover, integ-
rity of the VGF region is required for SH3 binding and
likely for subsequent formation of multi-protein com-
plexes. The fact that a multitude of Nef functions required
for enhancement of viral replication and disease progres-
sion are dependent on the formation of these protein
complexes suggests that the amphipathic region could
serve as a prime target for pharmaceutical intervention.
Availability of supporting data
Nucleotide sequences of isolated HIV-1 and HIV-2 Nef
alleles used in this study were submitted to Public
sequence repository (Genbank accession numbers JQ
990942 - JQ990960).
Methods
Viruses and Nef alleles
HIV-1 group M and group O isolates were obtained from
the AIDS Research and Reference Reagent Program, while
the HIV-2 strains were previously isolated from patients
attending the AIDS clinic at the Institute of Tropical Medi-
cine in Antwerp, Belgium, with the approval of the ethical
committee. Virus stocks were propagated and expanded in
short-term cultures of PBMCs treated with PHA (1 μg/mL)
and IL-2 (10 ng/mL). Genomic DNA was extracted using
the Qiagen Blood kit (Qiagen, Venlo, The Netherlands)
according to the manufacturer’s instructions. Nef alleles
from different HIV subtypes were amplified by semi-nested
polymerase chain reaction (PCR) with Platinum Pfx DNA
polymerase (Invitrogen, Merelbeke, Belgium). Primers rec-
ognizing Env and the 3’LTR regions of the HIV genome
used for the first round of PCR were forward: 5’-GCACT-
CAAGGCAAGCTTTATTGAGGC-3’ and reverse 5’-CCA-
CATACCTAGAAGAATAAGACAGG-3’. A nested PCR
reaction was performed after sequencing and using allele-
specific forward and reverse primers covering the complete
nef coding sequence and containing restriction sites for
BamHI and EcoRI, respectively (see Additional file 1: Table
S1A). Site specific mutants of Nef O8, VI1422, B2 and NA-7
in LZRS-IRES-eGFP were generated with PCR using allele
specific primers described in Additional file 1: Table S1B
and Table S1C.
Plasmid construction
Nef amplicons were cloned into the LZRS-IRES-eGFP
retroviral vector, using BamHI and EcoRI restrictions
sites [64]. Plasmids were purified with the Qiaprep Mini-
prep kit (Qiagen). The integrity of the constructs andthe nef genes was confirmed by direct sequencing (ABI,
Foster City, California). Alignments of the nef sequences
together with selected reference sequences were per-
formed using BioEdit version 5.0.9. Type, group and
subtype designation was confirmed by constructing
phylogenetic trees by the neighbor joining method using
MEGA 4 [65] (see Additional file 1: Figure S1).
Expression constructs for GFP fusion proteins of HIV-1
SF2 Nef, HIV-1 NA-7 Nef and SF2 AxxA were already
described and were constructed by cloning PCR fragments
of the respective nef genes into pEGFP-N1 (Clontech)
under the control of the cytomegalovirus promoter [26,31].
The expression constructs for NA7 Nef VGF ! AAA and
SF2 Nef VGF! AAA and NA-7 AxxA were generated by
site directed mutagenesis from the wild-type (WT) plasmid
(primers Additional file 1: Table S1D).
The proviral constructs used for HIV infectivity and repli-
cation assays are derived from the NLENG1-IRES vector
[66], which expresses HSA-IRES-Nef cloned in HIV-1 NL4-
3 provirus, as described before [40]. These constructs express
from the nef reading frame (together with Nef as two indi-
vidual proteins) mouse heat-stable antigen as a protein re-
porter. A BamH1/NgoMIV fragment corresponding to the
second exon of tat to the end of nef was cut out from the
vector and was ligated into pSUPER [67]. Next, SF2 and
NA-7 nef alleles and their specific AxxA and VGF mutants
were amplified by PCR using primers containing restriction
sites for BstXI and BspEI from the pEGFP-N1 vectors
described above. A nef allele, with deleted initiation codon,
two in frame stop codons at amino acid positions 4 and 5
and premature stop codons at positions 73 and 74 in the nef
ORF, disrupting the nef gene was generated by standard PCR
and cloning techniques, similarly to what was described be-
fore (Nefstop) [43]. The amplified nef alleles were subse-
quently cut with BstXI and BspE and ligated into the
pSUPER plasmid, swapping it with the WT nef present.
NL4.3 AxxA and VGF!AAA mutants were generated based
on the pSUPER vectors by site directed mutagenesis. Next,
BamH1/NgoMIV fragments of newly constructed pSUPER
plasmids were ligated into the NL4-3 HSA-IRES-Nef proviral
construct. All these final proviral constructs were verified for
correct nef allele sequence by direct sequencing.
The vector for the 764 amino acid p59Hck-mCherry fu-
sion protein was constructed by PCR amplifying human
Hck cDNA insert from the image clone 4855747 using
primers containing BglII (sense) and KpnI (antisense), and
inserting it between the BamHI and KpnI sites of the
pEBB vector [68], followed by cloning of red fluorescent
protein mCherry (Clontech) between the KpnI and EagI
sites after the p59Hck insert.
Cell lines, transfection, transduction and flow cytometry
Jurkat TAg [26,29] and Jurkat CD4-CCR5 (Programme
EVA Centre for AIDS Reagents, NIBSC, U.K.), are both
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TAg cells express the large T antigen of simian virus 40 and
were grown in RPMI 1640 medium supplemented with
10% fetal calf serum (FCS, Hyclone), 100 U/mL penicillin,
and 100 g/mL streptomycin (both from Gibco). Jurkat
CD4-CCR5 cells were grown in IMDM medium supple-
mented with 2 mM L-glutamin, 10% heat-inactivated fetal
calf serum (FCS), 293 T cells (American Type Culture Col-
lection (ATCC) Manassas, VA) were maintained in IMDM
medium, supplemented with 10% FCS, 2 mM L-glutamin,
100 U/mL penicillin, and 100 U/mL streptomycin.
Mouse antihuman monoclonal antibodies used were:
CD4 (clone SK3; [PE] and [APC]), anti-CXCR4, anti-
MHC-I [PE] (anti-human histocompatibility leukocyte
antigens [HLA]-A,-B,-C), all purchased from Becton
Dickinson Immunocytometry systems (Beckton Dickinson,
Erembodegem, Belgium) and anti-mouse-CD24-APC
(HSA, heat stable antigen; BioLegend, San Diego, CA).
The cells were analyzed on a FACSCalibur flow cytometer
(Becton Dickinson). Forward light scattering, orthogonal
scattering, and fluorescence signals were stored and ana-
lyzed using the CellQuest software (Becton Dickinson).
Cells were transfected using either calcium-phosphate
precipitation (Invitrogen, Merelbeke, Belgium) or JetPei
(Polyplus, Sélestat, France) according to the description
of the manufacturer. For transduction of suspension cell
lines, cells were mixed with retroviral supernatant, pre-
incubated with DOTAP (Roche diagnostics). To increase
transduction efficiency, cells were centrifuged (90 min-
utes, 950 g, 32°C) [64].
Production of retroviral vectors and replication
competent HIV
To produce retroviral vectors, the Phoenix-Amphotropic
packaging cell line was transfected with LZRS-IRES-eGFP
(control) and LZRS-Nef-IRES-eGFP plasmids using
calcium-phosphate precipitation as previously described
[17,64,69].
Replication competent HIV was produced by trans-
fecting 293 T cells with the HIV-1 NL4-3 –HSA-IRES-
Nef proviral constructs described above using the JetPEI
method. The medium was changed after overnight incu-
bation, and virus was harvested 24 h later and stored at
−80°C. The content of viral p24 antigen was quantified
using a HIV p24 enzyme-linked immunosorbent assay
kit (Innogenetics, Ghent, Belgium).
Immunofluorescence
Immunofluorescence stainings were performed as previ-
ously described [26,28]. Briefly, for staining of F-actin
(0.5 ng/ml phalloidin-TRITC), cells were fixed for
15 min with 3,7% paraformaldehyde (PFA)/phosphate-
buffered saline (PBS), permeabilized with 0.1% Triton X-
100/PBS for 2 min and subsequently blocked forunspecific binding with 1% bovine serum albumin
(BSA)/PBS for 15 min. Hoechst 33258 was used in a
concentration of 1 ng/ml. For staining of phospho-cofilin
(p-cofilin) (cell signaling) (1:50), and Lck (Santa Cruz)
(1:50) all solutions, dilutions, and wash steps were done
with Tris-buffered saline (TBS; 50 mM Tris, 150 mM
NaCl [pH 7.5]). Blocking was performed for 30 min, and
incubation was performed with the first antibody over-
night at 4°C. Confocal pictures of p-cofilin in Jurkat T cells
were acquired using a Zeiss LSM 510 Axiovert micro-
scope and LSM Meta software. Images were processed
using Adobe Photoshop CS3.
In vitro kinase assay
In vitro kinase assays (IVKA) were essentially performed
as described previously [26]. Briefly, Jurkat T lympho-
cytes were transfected with expression plasmids for Nef.
eGFP. After 24 h, cells were lysed in KEB (137 mM
NaCl, 50 mM Tris/HCl [pH 8], 2 mM EDTA, 0.5% Non-
indet P-40, and protease inhibitors) supplemented with
Na3VO4, and cleared lysates were sampled for Western
blot and immunoprecipitated with a rabbit anti-GFP
antibody. After intensive washing in KEB, the immuno-
precipitates were resuspended in KAB (50 mM HEPES
[pH 8], 150 mM NaCl, 5 mM EDTA, 0.02% Triton X-
100, 10 mM MgCl2) containing 10 μCi of [γ-32P]ATP
per reaction. After incubation for 10 min, samples were
washed, and bound proteins were separated by SDS-
PAGE and subjected to autoradiography. The kinase sig-
nal was quantified relative to the SF2 nef allele using
Quantity One (Bio-Rad).
Co-immunoprecipitation
For the Nef–Hck co-immunoprecipitation experiments,
293 T cells were transfected with expression plasmids
for Nef.eGFP and p59Hck (Cherry fusion protein). After
24 h, cells were lysed in KEB (137 mM NaCl, 50 mM
Tris/HCl [pH 8], 2 mM EDTA, 0.5% Nonidet P-40, and
protease inhibitors) supplemented with Na3VO4, and
cleared lysates were immunoprecipitated with a GFP-
Trap (Chromotek, Planegg-Martinsried, Germany). After
intensive washing in KEB, the precipitate was incubated
in anti-Hck Santa Cruz Biotechnology inc. Santa Cruz,
US), diluted 1:1000 in 50% blocking buffer.
Western blotting
Nef transduced Jurkat CD4-CCR5 cells sorted for eGFP
expression, were lysed in laemmli sample buffer. Equal
amounts of protein (40 μg) were run on a 12% precast
NuPAGE 4-12% Bis-Tris polyacrylamide gel (Invitrogen)
in reducing conditions and blotted onto a polyvinyldi-
fluoride (PVDF) membrane (Invitrogen). Primary anti-
bodies used were sheep-anti-Nef antiserum (Programme
EVA Centre for AIDS Reagents, NIBSC, UK.). Detection
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Healthcare, Chalfont St. Gilles, UK). To control that an
equal amount of protein was loaded for each sample,
blots were also stained for β-actin (primary anti-β-actin
antibody: clone C4, ICN, Aurora, OH, USA).
Infectivity assays
Virus infectivity was determined using P4R5 HeLa reporter
cells (NIH AIDS Reference and Reagent Program) [70].
Briefly, the cells were sown out in 96-well dishes in a vol-
ume of 200 μl IMDM supplemented with 2 mM L-gluta-
min and 10% FCS and infected after overnight incubation
with virus stocks containing 40 ng of p24 antigen (Innoge-
netics, Zwijnaarde, Belgium) produced by transiently trans-
fected 293 T cells and centrifuged (90 minutes, 950 g, 32°
C). 48 hours postinfection viral infectivity was detected
using a beta-galactosidase screen kit from Thermo scien-
tific (Pierce Biotechnology, Rockford, USA) as recom-
mended by the manufacturer. β-Galactosidase activities
were quantified as relative light units per second using an
Orion Microplate Luminometer. To calculate percent
values, relative light units per second obtained for wild-type
HIV-1 NL4-3 HSA-IRES Nef infection were set to 100%.
Viral replication in CD4+ PBL cultures
To determine the efficiency of HIV-1 replication in per-
ipheral blood CD4+ lymphocytes, we isolated CD4+ cells
from buffy coat peripheral blood mononuclear cells
(normal blood donors, Red Cross, Ghent, Belgium) by
negative selection using paramagnetic beads (MACS;
Miltenyi Biotec, Bergish Gladbach, Germany). After iso-
lation, the cells were cultured in RPMI medium supple-
mented with 2 mM L-glutamin, 10% heat-inactivated
fetal calf serum, phytohemagglutinin (1 μg/mL; Thermo
Fisher Scientific, Waltham, USA), 20 ng/mL IL-2
(Peprotech, Rocky Hill, USA), 100 U/mL penicillin, and
100 g/mL streptomycin. Thereafter, 1 ng of p24 antigen
was added to 2,5*105 PBLs, and the culture was spinocu-
lated at 2,300 rpm for 90 minutes at 32°C. After centri-
fugation, the supernatant was removed and the cells
were further cultured in RPMI supplemented with
20 ng/mL IL-2. HIV replication was monitored at 1, 3, 5,
7, 9 and 11 days post-infection by measuring the amount
of p24 antigen present in the supernatants, using a HIV
p24 enzyme-linked immunosorbent assay kit (Innoge-
netics, Ghent, Belgium). Alternatively, we also deter-
mined the expression of the HSA reporter gene at each
time point using flow cytometry, as was described before
[40].
Statistical analysis
Data were analysed with non-parametric Mann–Whit-
ney U test, one-tailed (SPSS, version 17; SPSS, Chicago,
USA).Additional File
Additional file 1: Figure S1. Alignment of the protein sequences
and evolutionary relationship of the isolated HIV-1 and HIV-2 Nef
proteins. (A) The evolutionary history was inferred using the neighbor-
joining (NJ) method as conducted in MEGA 4. (B–E) Amino acid
sequence alignments relative to references sequences, obtained from the
Los Alamos database HIV sequence database. Dots connote identity with
the reference sequence, whereas individual variations are shown by the
single letter amino acid code. Dashes indicate gaps introduced into the
sequence to optimize the alignment. (B) Alignment of HIV-1 group M
subtype B Nef amino acid sequences. (C) Alignment of HIV-1 group M
subtype C Nef amino acid sequences. (D) Alignment of HIV-1 group O
Nef amino acid sequences. (E) Alignment of HIV-2 Nef amino acid
sequences. Table S1. A) Allele-specific primers covering the complete
Nef coding sequence. B) Primers to generate site-specific mutants in Nef
O8. C) Primers to generate VGF!AAA mutants (indicated by ΔVGF) in B2,
VI1422, NA-7 and NL4.3 Nef. D) Primers for site specific mutagenesis of
NA-7.GFP and SF2.GFP fusion proteins and NL4.3.
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